BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15382281)

  • 1. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A; Frascarelli M; Uccini S; Novelli A
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease.
    Weimer LH; Podwall D
    J Neurol Sci; 2006 Mar; 242(1-2):47-54. PubMed ID: 16386273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A.
    Graf WD; Chance PF; Lensch MW; Eng LJ; Lipe HP; Bird TD
    Cancer; 1996 Apr; 77(7):1356-62. PubMed ID: 8608515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease.
    Neumann Y; Toren A; Rechavi G; Seifried B; Shoham NG; Mandel M; Kenet G; Sharon N; Sadeh M; Navon R
    Med Pediatr Oncol; 1996 Apr; 26(4):280-3. PubMed ID: 8600343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
    Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
    Cil T; Altintas A; Tamam Y; Battaloğlu E; Isikdogan A
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.
    Porter CC; Carver AE; Albano EA
    Pediatr Blood Cancer; 2009 Feb; 52(2):298-300. PubMed ID: 18837430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease].
    Uno S; Katayama K; Dobashi N; Hirano A; Ogihara A; Yamazaki H; Usui N; Kobayashi T; Inoue K; Kuraishi Y
    Rinsho Ketsueki; 1999 May; 40(5):414-9. PubMed ID: 10390891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma.
    Wanschitz J; Dichtl W; Budka H; Löscher WN; Boesch S
    Muscle Nerve; 2006 Oct; 34(4):494-8. PubMed ID: 16671108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.
    Olek MJ; Bordeaux B; Leshner RT
    J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vincristine neurotoxicity in the presence of hereditary neuropathy.
    Trobaugh-Lotrario AD; Smith AA; Odom LF
    Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
    [No Abstract]   [Full Text] [Related]  

  • 14. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.
    Mercuri E; Poulton J; Buck J; Broadbent V; Bamford M; Jungbluth H; Manzur AY; Muntoni F
    Arch Dis Child; 1999 Nov; 81(5):442-3. PubMed ID: 10519723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with vincristine--associated neurotoxicity.
    Othieno-Abinya NA; Nyabola LO
    East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the duplication of 17p11.2-12 chromosome region in the patients with hereditary motor and sensory neuropathy type 1A].
    Hryshchenko NV; Bychkova AM; Pichkur NA; Skyban HV; Dmytrenko VV; Livshyts' LA
    Tsitol Genet; 2003; 37(6):55-9. PubMed ID: 15067947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy).
    Igarashi M; Thompson EI; Rivera GK
    Med Pediatr Oncol; 1995 Aug; 25(2):113-6. PubMed ID: 7603395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient with both Charcot-Marie-Tooth disease (CMT 1A) and mild spinal muscular atrophy (SMA 3).
    Jedrzejowska M; Ryniewicz B; Kabzińska D; Drac H; Hausmanowa-Petrusewicz I; Kochański A
    Neuromuscul Disord; 2008 Apr; 18(4):339-41. PubMed ID: 18337101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A.
    Kashork CD; Chen KS; Lupski JR; Shaffer LG
    Ann N Y Acad Sci; 1999 Sep; 883():457-9. PubMed ID: 10586272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.